Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest Bacteriophages Stories

2009-11-18 15:30:20

Viruses are well known for attacking humans and animals, but some viruses instead attack bacteria. Texas A&M University researchers are exploring how hungry viruses, armed with transformer-like weapons, attack bacteria, which may aid in the treatment of bacterial infections. The Texas A&M researchers' work is published in the renowned journal Nature Structural & Molecular Biology. The attackers are called phages, or bacteriophages, meaning eaters of bacteria. The word...

2009-06-22 10:44:34

Research at the University of Leicester is focussing on a major killer in UK hospitals.In England and Wales, the national health statistics in 2007 showed that there were 8,324 death certificates which named Clostridium difficile. This is a bacterium which causes severe diarrhoea in humans and animals as the underlying cause of death, a 28% increase from 2006.Now Janet Nale of the Department of Infection, Immunity and Inflammation is investigating the contributing factors that make...

2009-01-13 15:34:00

LONGMONT, Colo., Jan. 13 /PRNewswire/ -- A new bacterial identification test that rapidly identifies MRSA infections moved closer to market with conclusion of its first multicenter clinical trial, which was announced today by MicroPhage, Inc., http://www.microphage.com. The company also reported the trial results have surpassed its early-stage performance expectations. (Photo: http://www.newscom.com/cgi-bin/prnh/20090113/AQTU542) The beta-site study evaluated MicroPhage's...

2008-12-09 12:58:07

U.S. university researchers say they've uncovered clues from a virus quirk that may lead to new ways to kill E. coli bacteria, which can be fatal to humans. The team from Penn State University said they learned how and why a particular virus injects an RNA polymerase -- an enzyme catalyzing polymer -- into an E. coli bacterial cell, the university said in a new release. The results help advance understanding of infection tactics used by viruses attacking bacterial cells -- which may lead to...

2008-08-06 09:01:05

Dyax Corp. (NASDAQ: DYAX) announced today that it has entered into a $50 million loan agreement with Cowen Healthcare Royalty Partners, L.P. ("CHRP") secured by the Company's phage display Licensing and Funded Research Program ("LFRP"). The Company used the proceeds from the loan, in part, to repurchase the LFRP revenue interest granted to Paul Capital Partners' Paul Royalty Fund II, L.P in August 2006, resulting in net proceeds of approximately $15 million, before transaction fees. The...

2008-07-29 09:00:55

OmniLytics, Inc. today announced the issuance of a no objection letter from the USDA's Food Safety and Inspection Service (FSIS) for use of Salmonella targeted bacteriophages from OmniLytics, Inc. applied to poultry. This poultry application will be jointly pursued in connection with OmniLytics collaboration with Elanco, the animal health division of Eli Lilly and Company (NYSE: LLY). The bacteriophage products will be used to reduce the level of Salmonella contamination on the feathers...

2008-07-22 09:01:13

Dyax Corp. (NASDAQ: DYAX) and AVEO Pharmaceuticals, Inc. announced today that Dyax has granted AVEO a non-exclusive license to Dyax's proprietary antibody phage display libraries for the discovery and development of therapeutic antibodies. Dyax's human antibody phage libraries combine gene fragments from human donors with strategically designed synthetic DNA, and are used to identify high-affinity human antibodies that bind to numerous therapeutic targets, including cell surface proteins such...

2007-05-02 03:00:26

The human antibody company, Affitech AS, announced today that it has further strengthened its intellectual property (IP) position in the human antibody discovery area through a series of IP cross-licensing and in-licensing deals. The Company's primary antibody library display patents are known as "Breitling" IP. Originating from the DKFZ (German Cancer Research Center) of Heidelberg, Germany, the Breitling patents cover the use of full-length pIII phage protein as a scaffold in a...


Latest Bacteriophages Reference Libraries

45_d6004cdea3a5384bdabb52dab5ce8f03
2011-04-18 21:37:33

Klebsiella pneumoniae is a Gram-negative, non-motile, encapsulated, lactose fermenting, facultative anaerobic, rod shaped bacterium found in the normal flora of the mouth, skin, and intestines. It is the most important member of the Klebsiella genus of Enterobacteriaceae. It is naturally occurring in soil and about 30% of strains can fix nitrogen in anaerobic conditions. Hans Christian Gram developed the technique now known as Gram staining in 1884 to discriminate between K. pneumoniae and...

More Articles (1 articles) »